9BFL

Solution structure of the scorpion toxin omega-Buthitoxin-Hf1a


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with acceptable covalent geometry 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Novel Scorpion Toxin omega-Buthitoxin-Hf1a Selectively Inhibits Calcium Influx via Ca V 3.3 and Ca V 3.2 and Alleviates Allodynia in a Mouse Model of Acute Postsurgical Pain.

Wang, D.Herzig, V.Dekan, Z.Rosengren, K.J.Payne, C.D.Hasan, M.M.Zhuang, J.Bourinet, E.Ragnarsson, L.Alewood, P.F.Lewis, R.J.

(2024) Int J Mol Sci 25

  • DOI: https://doi.org/10.3390/ijms25094745
  • Primary Citation of Related Structures:  
    9BFL

  • PubMed Abstract: 

    Venom peptides have evolved to target a wide range of membrane proteins through diverse mechanisms of action and structures, providing promising therapeutic leads for diseases, including pain, epilepsy, and cancer, as well as unique probes of ion channel structure-function. In this work, a high-throughput FLIPR window current screening assay on T-type Ca V 3.2 guided the isolation of a novel peptide named ω-Buthitoxin-Hf1a from scorpion Hottentotta franzwerneri crude venom. At only 10 amino acid residues with one disulfide bond, it is not only the smallest venom peptide known to target T-type Ca V s but also the smallest structured scorpion venom peptide yet discovered. Synthetic Hf1a peptides were prepared with C-terminal amidation (Hf1a-NH 2 ) or a free C-terminus (Hf1a-OH). Electrophysiological characterization revealed Hf1a-NH 2 to be a concentration-dependent partial inhibitor of Ca V 3.2 (IC 50 = 1.18 μM) and Ca V 3.3 (IC 50 = 0.49 μM) depolarized currents but was ineffective at Ca V 3.1. Hf1a-OH did not show activity against any of the three T-type subtypes. Additionally, neither form showed activity against N-type Ca V 2.2 or L-type calcium channels. The three-dimensional structure of Hf1a-NH 2 was determined using NMR spectroscopy and used in docking studies to predict its binding site at Ca V 3.2 and Ca V 3.3. As both Ca V 3.2 and Ca V 3.3 have been implicated in peripheral pain signaling, the analgesic potential of Hf1a-NH 2 was explored in vivo in a mouse model of incision-induced acute post-surgical pain. Consistent with this role, Hf1a-NH 2 produced antiallodynia in both mechanical and thermal pain.


  • Organizational Affiliation

    Department of Chinese Medicine and Pharmacy, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.


Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Buthitoxin-Hf1a11Hottentotta franzwerneriMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with acceptable covalent geometry 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Health and Medical Research Council (NHMRC, Australia)AustraliaAPP1072113

Revision History  (Full details and data files)

  • Version 1.0: 2024-06-05
    Type: Initial release